Central glucagon-like peptide-1 (GLP-1) is a target in treating obesity due to its effect on suppressing appetite, but the possible downstream key genes that GLP-1 regulated have not been studied in depth. The gene discussed is GCG; the disease is obesity due to melanocortin 4 receptor deficiency.